ORAMED PHARMACEUTICALS INC.·4

Sep 11, 5:17 PM ET

Sank Leonard 4

4 · ORAMED PHARMACEUTICALS INC. · Filed Sep 11, 2019

Insider Transaction Report

Form 4
Period: 2019-09-09
Sank Leonard
Director
Transactions
  • Purchase

    Common Stock

    2019-09-09$2.90/sh+15,000$43,500364,999 total
  • Purchase

    Common Stock

    2019-09-09$2.95/sh+10,000$29,500374,999 total
Holdings
  • Common Stock

    (indirect: By Trust)
    138,889
  • Common Stock

    (indirect: By Spouse)
    78,125
Footnotes (2)
  • [F1]Mr. Sank disclaims beneficial ownership of these shares.
  • [F2]These shares consist of shares of common stock owned by a company wholly owned by a trust of which Mr. Sank is a trustee. Mr. Sank disclaims beneficial ownership of these shares.

Documents

1 file
  • 4
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT